PHOTO
UAE: “A troubled stomach can’t be a good adviser”, an old Chinese proverb. Our stomach happens to be the birthplace of all the good and bad actions in our body to take shape. With this central theme of discussing the ailments of stomach and the latest approaches worldwide, the 4th International Conference on Gastroenterology was held over the weekend at Hotel InterContinental, Abu Dhabi, UAE.
Best global practices to over 400 doctors of UAE and the larger GCC were shared by Specialists and Consultants in the fields of GI Endoscopy, Gastro Oncology, GI Surgery, Pathologist and Radiologists who provided their insight into the realms of Gastroenterology.
The sessions were deliberated by some of the most eminent doctors like Dr. Sameer Al Awadhi, Head of Gastroenterology at Rashid Hospital, Professor Dr. Jurgen Stein, Head of Gastroenterology, Goethe University Frankfurt, Germany and Prof Dr. Ho Khek- Yu Lawrence, Director at Centre for Innovation in health care, National University Health system, Singapore and Dr. Yogesh Shastri, Consultant and Head, Dept. of Gastroenterology NMC Specialty Hospital, Abu Dhabi.
Some of the never before discussed topics were by Dr. Lawrence from Singapore who talked about his ongoing innovation in interventional capsule endoscopy and the role of Artificial Intelligence and Robotics in Gastroenterology and an educative lecture on Endoscopic Ultrasound (EUS), by Dr. Shastri, who claims having pioneered this procedure in Abu Dhabi conducting over 500 of them, explained how this procedure has revolutionized the clinical practice in the field of Gastroenterology, Oncology and GI Surgery.
In order to have an experiential and participative learning opportunities for the attendees, the most appreciated feature of this conference was the "LIVE TRANSMISSION" of Endoscopic Ultrasound from Center for Interventional endoscopy, Florida Hospital in Orlando by its Medical Director Dr. Shyam Varadarajulu where he shared live cases by a transmission link.
Commenting on the event, Prasanth Manghat, CEO & Executive Director, NMC Healthcare said: “As a leading healthcare company of the GCC, it is our responsibility to continue investing in such continuous medical education program ensuring knowledge development of the doctors of our country and the region at large.”
About NMC Health
NMC Health plc is the leading private sector healthcare operator based out of the United Arab Emirates. The group, having started its operations in the country in 1975, has an international network of hospitals in the UAE & GCC, Europe and South America consisting of over 200 healthcare facilities across 17 countries, catering to over 8.5 million patients per year, and employing over 2000 doctors and 18000 administrative and support staff.
The group is also a leading UAE distributor of products and consumables across several key market segments, with the major contribution coming from healthcare related products. NMC Trading, a subsidiary of NMC Health plc, is one of the largest distributors in the UAE with distribution rights for some of the most iconic brands from around the world, including 3M, Medtronic, Welch Allyn, Meyra, Sorg, Patron, Abbott Diabetes Care, Nestle, Unilever, Nivea, Pfizer, Siemens, Samsung, Sanofi, Kiwi, Brylcreem, and Henkel, among others. NMC Trading sells products and services to over 10,000 businesses across the UAE.
NMC Health plc reported revenues of US$1603.4 m in 2017. In April 2012 NMC Health plc became the first healthcare company from the GCC to list on the London Stock Exchange (LSE). NMC Health plc is a constituent of the coveted FTSE 100 Index of the blue-chip companies at the LSE.
To find out more visit: https://nmc.ae/
© Press Release 2018Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
